InvestorsHub Logo
Followers 839
Posts 120491
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 2252

Tuesday, 06/21/2022 5:17:46 PM

Tuesday, June 21, 2022 5:17:46 PM

Post# of 3223
(ENTA)—PFE’s guidance for 2022 Paxlovid sales is $22B, of which a substantial portion is from the US market.

If ENTA’s patent suit resulted in even a low-single-digit royalty on US sales of Paxlovid, it would amount to a very sizable payday relative to ENTA’s existing enterprise value.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News